Guangji Pharmaceutical Industry: Wholly-owned subsidiary completes acquisition of 49% equity stake in a subsidiary company.

Guangji Pharmaceutical announced that its wholly-owned subsidiary Jikang Company and Tongke Management jointly established Changjiang Guangji Company, with Jikang Company originally holding 51% of the shares. Based on the company's operating situation, Jikang Company acquired the 49% equity of Changjiang Guangji Company held by Tongke Management at a price of 0 yuan. This transaction has undergone internal approval procedures, does not constitute a related party transaction or a major asset restructuring. Recently, Changjiang Guangji Company completed the industrial and commercial registration procedures. After the transaction is completed, Jikang Company's shareholding ratio will increase to 100%, the company's consolidated financial statements scope remains unchanged, and there is no significant adverse impact on operating performance and financials.